Author： Rios S L Baracho V G Oliveira KB A Rizzo Prof. Luiz Vicente
Publisher： Informa Healthcare
ISSN： 1354-3776
Source： Expert Opinion on Therapeutic Patents, Vol.17, Iss.4, 2007-04, pp. : 407-418
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Comparative Tolerability of Therapies for Cytomegalovirus Retinitis
By Walmsley S.
Drug Safety, Vol. 21, Iss. 3, 1999-09 ,pp. :
Access to resources
Recommend
By Nachmani Daphna Mandelboim Ofer
Future Virology, Vol. 6, Iss. 8, 2011-08 ,pp. :
Focus on New Drugs in Development Against Human Cytomegalovirus
By Emery V.C. Hassan-Walker A.F.
Drugs, Vol. 62, Iss. 13, 2002-01 ,pp. :